Free Trial

Aveanna Healthcare (AVAH) Stock Forecast & Price Target

$2.78
-0.02 (-0.71%)
(As of 04:00 PM ET)

Aveanna Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Reduce
Based on 5 Analyst Ratings

Consensus Price Target

$1.80
-35.25% Downside
High Forecast$3.00
Average Forecast$1.80
Low Forecast$1.00
TypeCurrent Forecast
5/29/23 to 5/28/24
1 Month Ago
4/29/23 to 4/28/24
3 Months Ago
2/28/23 to 2/28/24
1 Year Ago
5/29/22 to 5/29/23
Consensus Rating
Reduce
Reduce
Sell
Reduce
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
5 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$1.80$1.80$1.78$2.34
Forecasted Upside-35.25% Downside-18.00% Downside-7.47% Downside50.34% Upside
Get Aveanna Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.

AVAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AVAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Aveanna Healthcare Stock vs. The Competition

TypeAveanna HealthcareMedical CompaniesS&P 500
Consensus Rating Score
1.60
2.70
2.49
Consensus RatingReduceModerate BuyHold
Predicted Upside-35.71% Downside835.22% Upside9.93% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/18/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$2.00 ➝ $3.00+23.46%
12/13/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight
11/30/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$1.50-48.10%
8/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderperform ➝ Underperform$1.00-45.05%
7/13/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$1.40 ➝ $1.70+3.66%
5/12/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Market Perform
11/21/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Sector Perform$7.00 ➝ $3.00+287.04%
11/11/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$2.25 ➝ $1.50+48.51%
8/19/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$7.00 ➝ $5.00+134.74%
7/22/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$2.50+12.11%
6/21/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$3.00 ➝ $2.00-14.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:53 PM ET.

AVAH Frequently Asked Questions

What is Aveanna Healthcare's stock forecast and purchase recommendation?

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Aveanna Healthcare is $1.80, with a high forecast of $3.00 and a low forecast of $1.00. The consensus rating for Aveanna Healthcare stock is Reduce based on the current 3 sell ratings, 1 hold rating and 1 buy rating for AVAH. Learn more on AVAH's analyst rating history.

Do Wall Street analysts like Aveanna Healthcare more than its competitors?

Analysts like Aveanna Healthcare less than other "medical" companies. The consensus rating for Aveanna Healthcare is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AVAH compares to other companies.

Does Aveanna Healthcare's stock price have much downside?

According to analysts, Aveanna Healthcare's stock has a predicted downside of -18.00% based on their 12-month stock forecasts.

What analysts cover Aveanna Healthcare?

Aveanna Healthcare has been rated by research analysts at Deutsche Bank Aktiengesellschaft in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:AVAH) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners